glp-1 alcohol addiction medications: The next big thing in use disorder treatment? – Recovery Research Institute IUPHAR review – Glucagon-like peptide-1

doi: 10.1016/j.neuropharm.2022.109127, PMID: [DOI] [PubMed] [Google Scholar] Pagni B

For context, Hims launched its comprehensive weight loss portfolio in December 2023 and complemented this offering in May 2024 by announcing GLP-1 access for Hims customers oral medication kits first for $79/month and then compounded GLP-1 injections for $199/month

They must follow whatever BCBS covers in your state

The temporal proximity between GLP1 analogue initiation and recurrence observed in our cohort may suggest a timelinked effect, although causality cannot be inferred from observational data

This effect is likely dependent on CB receptors, as 9 -THC can inhibit NK cell cytolytic activity, which could be reversed by antagonists targeting either CB1 or CB2 [99]

Not on the Bridge list